AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.65
5.16%
After-hours: Aug 15, 2025, 07:30 PM EDT

AIM ImmunoTech Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
PE Ratio
-56.95 -47.63 -105.22 -266.2 -104.15 -42.95 -71.56 -165.18 -182.75 -85.15 -111.56 -187.07 -283.39 -188.24 -631.53 -437.55 -725.06
PEG Ratio
1.14 -0.85 -1.24 3.74 1.93 -0.69 -1.19 -2.36 5.16 2.84 -3.72 -26.91 12.83 -3.76 18.95 -8.22 80.98
PS Ratio
52.75K 25.27K 44.49K 39.1K 60.59K 33.24K 48.64K 77.23K 42.47K 26.7K 132.79K 124.89K 154.16K 88.04K 292.88K 447.13K 370.71K
PB Ratio
-218.81 -860.01 534.78 320.38 502.16 211.11 98.98 107.63 59.48 38.86 65.31 76.81 95.45 77.39 155.77 156.93 146.27
P/FCF Ratio
n/a -279.07 -476.52 -603.95 -498.14 -217.01 -382.1 -1.37K -561.12 -239.42 -559.06 -1.59K -1.82K -746.07 -2.73K -5.9K -3.04K
P/OCF Ratio
n/a -287.47 -500.73 -649.93 -503.31 -221.41 -394.5 -1.5K -565.54 -246.32 -561.31 -1.62K -1.84K -766.2 -2.8K -5.99K -3.41K
OCF/S Ratio
n/a -87.89 -88.86 -60.16 -120.38 -150.12 -123.28 -51.38 -75.1 -108.38 -236.57 -77.1 -83.58 -114.9 -104.76 -74.7 -108.75
Debt / Equity Ratio
-0.65 -2.22 1.17 0.55 0.69 0.07 0.03 0.03 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.00 0.03
Quick Ratio
0.26 0.44 0.75 1.17 1.14 1.68 4.82 10.01 18.05 26.69 14.21 33.66 60.68 74.61 49.59 47.17 52.80
Current Ratio
0.26 0.44 0.75 1.17 1.14 1.68 4.82 10.01 18.05 26.69 14.21 33.66 65.77 74.61 49.59 47.17 52.80
Asset Turnover
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest Coverage
-29.19 105.43 -22.22 -20.64 -79.64 -22.07 n/a n/a n/a n/a n/a n/a n/a n/a -196.45 -195.68 -74.9
Return on Equity
0.96 4.51 -1.27 -0.3 -1.21 -1.23 -0.35 -0.16 -0.08 -0.11 -0.15 -0.1 -0.08 -0.1 -0.06 -0.09 -0.05
Return on Assets
-0.59 -0.69 -0.27 -0.12 -0.36 -0.65 -0.28 -0.15 -0.08 -0.11 -0.14 -0.1 -0.08 -0.1 -0.06 -0.09 -0.05
Return on Invested Capital
2.71 8.57 -0.71 -0.39 -0.7 -1.27 -0.33 -0.18 -0.09 -0.14 -0.15 -0.1 -0.07 -0.13 -0.06 -0.06 -0.05
Dividend Yield
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin
0.38 0.84 0.77 0.84 -0.65 -0.08 0.35 -1.17 -0.71 1.00 -309.52 -1.3 -1.33 -2.52 -3.76 -11.13 -7.46
Net Profit Margin
-231.56 -132.6 -105.71 -36.72 -145.43 -193.48 -169.91 -116.88 -58.1 -78.38 -297.57 -166.9 -136 -116.92 -115.94 -255.48 -127.82
Pretax Profit Margin
-231.56 -132.6 -105.71 -36.72 -145.43 -193.48 -169.91 -116.88 -74.71 -78.38 -304.05 -161.7 -115.76 -116.92 -115.94 -255.48 -127.82
Operating Profit Margin
-226.19 309.27 -128.26 -73.88 -143.35 -215.23 -169.91 -130.02 -87.65 -99.21 -310.52 -156.5 -95.52 -148.9 -119.06 -161.65 -133.75
FCF Margin
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin
-216.19 -128.24 -98.14 -31.92 -142.18 -214.55 -176.17 -114.71 -73 -75.34 -309.19 -160.73 -94.64 -113.14 -110.21 -246.43 -117.54